ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Launched by KESTRA MEDICAL TECHNOLOGIES, INC. · Nov 24, 2021

Keywords

ClinConnect Summary

The ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS) is a research study looking at the use of a special wearable device called the ASSURE wearable cardioverter defibrillator (WCD). This device helps people who are at risk of sudden cardiac arrest by monitoring their heart and providing treatment if needed. The study uses real-world data from patients who have already agreed to participate in the ASSURE Patient Registry. Researchers will analyze this information to see how well the device works and how it is used in everyday life.

To join this study, participants need to be adults who have been prescribed the ASSURE WCD and have given their permission to be part of the registry. The study welcomes all adult patients, particularly those aged 65 to 74. If you qualify and decide to participate, you can expect to contribute to important research that may help improve treatment for others at risk of sudden cardiac arrest. Additionally, this study is currently recruiting participants, so there’s an opportunity to join and help shape future cardiac care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patient prescribed the ASSURE wearable cardioverter defibrillator
• • Provided written informed consent to participate in the ASSURE Patient Registry
• Exclusion Criteria:
• • Patients who do not meet the Inclusion criteria